TScan Therapeutics (TCRX) Institutional Ownership $4.41 -0.41 (-8.51%) (As of 11/15/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for TScan Therapeutics (NASDAQ:TCRX)CurrentInstitutional OwnershipPercentage82.83%Number ofInstitutional Buyers(last 12 months)27TotalInstitutional Inflows(last 12 months)$20.10MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$3.47M Get TCRX Insider Trade Alerts Want to know when executives and insiders are buying or selling TScan Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TCRX Institutional Buying and Selling by Quarter Ad DTILet’s be bluntLet me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now TScan Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC973,466$4.85M0.0%+8.1%1.838% 11/15/2024Barclays PLC58,067$289K0.0%+341.1%0.110% 11/15/2024 XTX Topco Ltd22,438$112K0.0%N/A0.042% 11/15/2024Jane Street Group LLC93,876$468K0.0%-5.2%0.177% 11/15/2024 Wellington Management Group LLP126,345$629K0.0%+38.9%0.239% 11/15/2024 State Street Corp756,499$3.77M0.0%+24.4%1.428% Get the Latest News and Ratings for TCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 Stifel Financial Corp99,133$494K0.0%+3.9%0.187% 11/15/2024 Jacobs Levy Equity Management Inc.103,440$515K0.0%N/A0.195% 11/15/2024 Checkpoint Capital L.P.825,341$4.11M2.0%N/A1.558% 11/14/2024 Walleye Capital LLC84,699$422K0.0%-21.3%0.160% 11/14/2024 MetLife Investment Management LLC23,363$116K0.0%+129.1%0.044% 11/13/2024 Great Point Partners LLC1,016,375$5.06M1.5%+8.0%1.919% 11/13/2024 Brown Brothers Harriman & Co.143,051$712K0.0%+88.2%0.270% 11/7/2024 LMR Partners LLP71,800$358K0.0%-89.2%0.136% 11/6/2024 Cornercap Investment Counsel Inc.10,788$54K0.0%-53.0%0.020% 10/25/2024 abrdn plc371,655$1.85M0.0%+27.2%0.702% 10/3/2024 SG Americas Securities LLC15,563$78K0.0%N/A0.029% 8/15/2024 The Manufacturers Life Insurance Company15,383$90K0.0%N/A0.029% 8/15/2024 Troluce Capital Advisors LLC92,832$543K0.1%N/A0.176% 8/14/2024 Great Point Partners LLC940,831$5.50M1.1%N/A1.780% 8/14/2024 Marshall Wace LLP307,487$1.80M0.0%+60.8%0.582% 8/14/2024 Bank of Montreal Can120,454$749K0.0%N/A0.228% 8/12/2024 Marathon Trading Investment Management LLC13,600$80K0.0%-73.3%0.026% 8/9/2024 Renaissance Technologies LLC80,000$468K0.0%+70.2%0.151% 8/9/2024 Dimensional Fund Advisors LP11,882$70K0.0%N/A0.022% 8/9/2024 Brown Brothers Harriman & Co.76,024$445K0.0%N/A0.144% 8/8/2024 Cornercap Investment Counsel Inc.22,940$134K0.0%N/A0.043% 8/8/2024 American Century Companies Inc.47,481$278K0.0%+48.9%0.090% 8/2/2024 Privium Fund Management UK Ltd12,103$69K0.0%-23.5%0.023% 8/1/2024 Rhumbline Advisers46,867$274K0.0%N/A0.089% 7/26/2024 Bank of New York Mellon Corp116,658$682K0.0%N/A0.221% 5/10/2024 Vanguard Group Inc.1,808,152$14.36M0.0%+1.1%3.776% 5/10/2024 Tocqueville Asset Management L.P.212,200$1.69M0.0%N/A0.443% 4/17/2024 Cannon Global Investment Management LLC17,500$139K0.4%N/A0.037% 2/14/2024 Pale Fire Capital SE21,573$126K0.0%+30.2%0.045% 2/12/2024 Letko Brosseau & Associates Inc.20,700$121K0.0%-36.1%0.043% 1/31/2024 abrdn plc200,000$1.17M0.0%N/A0.418% 11/14/2023 Pale Fire Capital SE16,575$42K0.0%N/A0.035% 11/9/2023 Letko Brosseau & Associates Inc.32,400$83K0.0%N/A0.068% 8/15/2023 BVF Inc. IL2,989,474$7.47M0.2%N/A12.338% Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now8/10/2023 Monashee Investment Management LLC400,000$1M0.2%N/A1.651% 7/26/2023 Privium Fund Management B.V.15,825$40K0.0%N/A0.065% 5/10/2023 Simplify Asset Management Inc.546,916$1.15M0.2%N/A2.257% 2/15/2023 Tang Capital Management LLC514,655$798K0.1%-7.8%2.137% 11/16/2022 Alphabet Inc.1,077,080$3.29M0.2%N/A4.482% 11/15/2022 Tang Capital Management LLC557,915$1.70M0.2%-25.4%2.322% 11/4/2022 Prudential Financial Inc.11,000$34K0.0%N/A0.046% 11/1/2022 Privium Fund Management UK Ltd15,825$48K0.1%N/A0.066% 5/17/2022 RA Capital Management L.P.1,021,764$2.86M0.1%-18.6%4.299% 5/17/2022 Hhlr Advisors LTD.669,513$1.88M0.0%-47.8%2.817% 4/26/2022 Marquette Asset Management LLC28,895$81K0.0%+33.7%0.122% 2/15/2022 Deer Management Co. LLC1,245,505$5.61M0.1%N/A5.240% 2/15/2022 Adage Capital Partners GP L.L.C.550,000$2.48M0.0%+10.8%2.314% 1/19/2022 Marquette Asset Management LLC21,618$97K0.0%N/A0.091% 11/16/2021 Schonfeld Strategic Advisors LLC22,200$185K0.0%N/A0.093% 11/16/2021 Wellington Management Group LLP139,566$1.16M0.0%N/A0.582% 11/15/2021 RA Capital Management L.P.1,255,317$10.47M0.1%N/A5.238% 11/15/2021 Caas Capital Management LP75,000$626K0.0%N/A0.313% 11/12/2021 DC Investments Management LLC35,563$297K0.6%N/A0.148% 11/12/2021 DC Funds LP630,000$5.25M20.6%N/A2.629% 11/9/2021BlackRock Inc.1,500,577$12.52M0.0%N/A6.261% 11/9/2021 Monashee Investment Management LLC100,000$834K0.2%N/A0.417% (Data available from 1/1/2016 forward) TCRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TCRX shares? During the previous two years, 38 institutional investors and hedge funds held shares of TScan Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($14.36M), BVF Inc. IL ($7.47M), Great Point Partners LLC ($5.06M), Geode Capital Management LLC ($4.85M), Checkpoint Capital L.P. ($4.11M), State Street Corp ($3.77M), and abrdn plc ($1.85M).Learn more on TCRX's institutional investors. What percentage of TScan Therapeutics stock is owned by institutional investors? 82.83% of TScan Therapeutics stock is owned by institutional investors. Learn more on TCRX's institutional investor holdings. Which institutional investors have been buying TScan Therapeutics stock? Of the 32 institutional investors that purchased TScan Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2.99M), Great Point Partners LLC ($1.02M), Checkpoint Capital L.P. ($825.34K), Simplify Asset Management Inc. ($546.92K), Monashee Investment Management LLC ($400K), abrdn plc ($279.51K), and Tocqueville Asset Management L.P. ($212.20K). How much institutional buying is happening at TScan Therapeutics? Institutional investors have bought a total of 7,572,120 shares in the last 24 months. This purchase volume represents approximately $29.88M in transactions. Which TScan Therapeutics major shareholders have been selling company stock? The following institutional investors have sold TScan Therapeutics stock in the last 24 months: LMR Partners LLP ($593.73K), Tang Capital Management LLC ($43.26K), Marathon Trading Investment Management LLC ($37.40K), Walleye Capital LLC ($22.97K), Cornercap Investment Counsel Inc. ($12.15K), Letko Brosseau & Associates Inc. ($11.70K), and Jane Street Group LLC ($5.16K). How much institutional selling is happening at TScan Therapeutics? Institutional investors have sold a total of 730,089 shares in the last 24 months. This volume of shares sold represents approximately $3.53M in transactions. Related Companies Fate Therapeutics Institutional Ownership Nkarta Institutional Ownership Adaptimmune Therapeutics Institutional Ownership Voyager Therapeutics Institutional Ownership Absci Institutional Ownership CASI Pharmaceuticals Institutional Ownership Champions Oncology Institutional Ownership Achilles Therapeutics Institutional Ownership Adaptive Biotechnologies Institutional Ownership Applied Therapeutics Institutional Ownership This page (NASDAQ:TCRX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TScan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
